In vitro antiamoebic activity of Iranian Allium sativum in comparison with Metronidazole against Entamoeba histolytica

Iranian Journal of Parasitology

Volumn 3, Issue 4, 2008, Pages 32-38

  Behnia, M ^a   Haghighi, A ^b   Komeilizadeh, H ^c   Seyyed Tabaei, S J ^b   Abadi, A ^c  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Allium sativum; Antiamoebic; Entamoeba histolytica

Indexed keywords

EID: 84875081703     PISSN: 17357020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Walsh JA. Prevalence of Entamoeba histolytica infection. In: Ravdin JI, editor. Amoebiasis. New York: John Wiley & Sons; 1988. p. 93-105.
2. Petri Jr WA, Mann BJ. Molecular mechanisms of invasion by Entamoeba histolytica. Semin Cell Bio. 1993;4(5): 305-13.
3. Ravdin JI. Amebiasis. Clin Infect Dis. 1995;20(6):1453-64.
4. Hooshyar H, Rezaian M, Kazemi B, Jeddi-Tehrani M, Soleymani-Mohammadi S. The distribution of Entamoeba histolytica and Entamoeba dispar in northern, central and southern Iran. Parasitol Res. 2004;94(2):96-100.
5. Tracy JW, Webster JLT. Drugs used in the chemotherapy of protozoal infection. In: Hardman JG, Limbird LE, editors. The Pharmacological Basis of Therapeutics. New York: McGraw-Hill; 1996. p. 987-1008.
6. Legator MS, Connor TH, Stoeckel M. Detection of mutagenic activity of metronidazole and niridazole in body fluids of humans and mice Science. 1975;188 (4193):1118-9.
7. Rustia M, Shubik P. Induction of lung tumors and malignant lymphomas in mice by metronidazole. J Natl Cancer Inst. 1972;48(3):721-9.
8. Shubik P. Current status of chemical carcinogens. Proc Natl Acad Sci USA. 1972; 69(4):1052-5.
9. Zwet AA, Thijs JC, Schievink-de Vries W, Schiphuis J, Snijder JAM. In vitro studies on stability and development of metronidazole resistance in Helicobacter pylori. Antimicrob Agents Chemother. 1994;38(2):360-2.
10. Saxena A, Chugh S, Vinayak VK. Modulation of host immune responses by metronidazole. Indian J Med Res. 1985; 81:387-90.
11. Kurohara ML, Kwong FK, Lebherz TB, Klaustermeyer WB. Metronidazole hypersensitivity and oral desensitization. J Allergy Clin Immunol. 1991;88(2):279-80.
12. Sharma VD, Sethi MS, Kumar A, Rarotra JR. Antibacterial property of Allium sativum Linn: in vivo and in vitro studies. Indian J Exp Biol. 1977;15(6):466-8.
13. Fenwick G R, Hanley AB. The genus Allium-part 3. Crit Rev Food Sci Nutr. 1985;23(1):1-73.
14. Yamada Y, Azuma K. Evaluation of the in vitro antifungal activity of allicin. Antimicrob Agents Chemother. 1997;11(4):743-9.
15. Milner JA. Garlic: its anticarcinogenic and anti tumorigenic properties. Nutr Rev. 1996;54(Suppl):82-86.
16. Kiesewetter H, Jung F, Jung EM, Mroweitz C, Koscrelny J, Wenzel E. Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischemic attacks. Eur J Clin Pharmocol. 1993; 45(4):333-6.
17. Darbyshire B, Henry RJ. Differences in fructan content and synthesis in some Allium species. New Phytol. 1981;87(2): 249-56.
18. Koch HP, Lawson LD. Garlic, the science and therapeutic application of Allium sativum L. and related species. In: Retford DC, editor. Baltimore: Williams and Wilkins; 1996. p. 213-233.
19. Calzada F, Alanis AD, Meckis M, Contreras A, Cedillo-Rivera R. In vitro susceptibility of Entamoeba histolytica and Giardia lamblia to some medicinal plants used by the people of Southern Mexico. Phyto Res. 1998;12:70-2.
20. Mirelman D, Monheit D, Varon S. Inhibition of growth of Entamoeba histolyica by allicin, the active principle of garlic extract (Allium sativum). J Infect Dis. 1987;156(1):243-4.
21. Soffar SA, Mokhtar GM. Evaluation of the antiparasitic effect of aqueous garlic (Allium sativum) extract in hymenolepiasis nana and giardiasis. J Egypt Soc Parasitol. 1991;21(2):497-502.
22. Lun ZR, Burri C, Menzinger M, Kaminsky R. Antiparasitic activity of diallyl trisulphide (dasuansu) on human and animal pathogenic protozoa (Trypanosoma sp., Entamoeba histolyica and Giardia lamblia) in vitro. Ann Soc Belg Med Trop. 1994;74(1):51-9.
23. Schaffer S. Understanding local Mediterranean diets: A multidisciplinary pharmacological and ethnobotanical approach. Pharmacol Res. 2005;52(4):353-6.
24. Goodner KL, Mahattanatawee K, Plotto A, Sotomayor JA, Jordán MJ. Aromatic profiles of Thymus hyemalis and Spanish T. vulgaris essential oils by GC-MS/GC-O. Indust Crops Prod. 2006;24(3):264-268.
25. Diamond LS, Harlow DR, Cunnick CC. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans Roy Soc Trop Med Hyg. 1978;72(4):431-2.
26. Padayachee T, Odhav B. Anti-amoebic activity of plant compounds from Virgilia oroboides and Chlorophora excelsa. J Ethnopharmacol. 2001;78(1):59-66.
27. Bingham AK, Jarroll EL Jr, Meyer EA Radulescu S. Giardia sp; Physical factors of excystation invitro and excystation VS eosin exclusion as determinants of viability. Exp Parasitol. 1979;47(2):284-91.
28. Muelas-Serrano S, Nogal JJ, Martinez-Diaz RA, Escario JA, Martinez-Fernandez AR, Gomez-Barrio A. In vitro screening of American plant extracts on Trypanosoma cruzi and Trichomonas vaginalis. J Ethnopharmacol. 2000;71(1-2):101-7.
29. Taran M, Rezaeian M, Izaddoost M. Invitro Antitrichomonas Activity of Allium hirtifolium (Persian Shallot) in Comparison with metronidazole. Iranian J Pub Health. 2006;35(1):92-94.
30. Harris JC, Cottrell SL, Plunmer S, Lloyd D. Antimicrobial properties of Allium sativum (garlic). Appl Microbiol Biotechnol. 2001;57(3):282-6.
31. Newall CA, Anderson LA, Phillipson JD. In Herbal Medicines: A Guide for Healthcare Professionals. London: The Pharmaceutical Press; 1996; p. 129-133.